TFS Articles

Search by keyword, or choose a Focus Topic to view all articles within that area of study.

  • Clear Filters

Found 196 Results
Page 2 of 22
Article

ICH E6(R3) Is Here. Is Your Trial Ready?

Discover how TFS is helping sponsors prepare for ICH E6(R3) with proactive oversight, modern technologies, and quality-first trial design.

Read Now
Article

Neuroscience Clinical Research Trends in 2025: How Innovative CROs are Shaping the Future of Neurological Trials

From digital biomarkers to AI-enabled feasibility, explore the top trends reshaping CNS clinical trials in 2025 and how innovative CROs are helping sponsors bring neuroscience clinical research to life.

Read Now
Article

LGBTQIA+ Clinical Trials: A Decade of Progress and the Urgent Future of Inclusive Research

Explore a decade of progress and the critical next steps in LGBTQIA+ clinical trial inclusion.

Read Now
Article

Honoring Juneteenth: Advancing Health Equity Through Inclusive Clinical Research

Learn how TFS honors Juneteenth by promoting diversity and inclusion in clinical trials to improve global health outcomes.

Read Now
Article

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.

Read Now
Article

Top Technologies Transforming Decentralized Clinical Trials

Explore how decentralized clinical trials (DCTs) are transforming clinical research in 2025 through technologies like telehealth, wearables, and digital platforms.

Read Now
Article

Functional Service Provider (FSP) Models: A Strategic Imperative for Modern Clinical Development

Discover how the FSP model enhances trial agility, oversight, and scalability, providing a strategic advantage in 2025 clinical development.

Read Now
Article

Huntington’s Disease Clinical Trials: Innovation, Challenges, and the Road Ahead

Explore the latest advancements in Huntington’s disease therapeutics—from gene silencing and small molecules to digital biomarkers.

Read Now
Article

ARVO 2025 Highlights: Driving Innovation in Ophthalmic Drug Development

Learn how emerging therapies and technologies from ARVO are transforming the landscape of ophthalmology research, and why strategic partners like TFS are key to advancing clinical success.

Read Now